Publication | Open Access

Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex

Kat IiNeurophysiologyMedicineNeurotransmitterRat Prefrontal CortexNeuropharmacologyEvoked Glutamate ReleaseNeurotransmissionNeurologyCentral Nervous SystemNervous SystemNeurosciencePharmacologyNeurochemistryDopamineSocial Sciences